Status:
RECRUITING
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Atopic Disorders
Eligibility:
All Genders
6+ years
Brief Summary
The Atopy Registry aims to assess data about atopic disorders and their medical care in a standardized form. With this, the comparative efficacy, tolerability and safety of systemic therapies for atop...
Detailed Description
The prevalence of atopic disorders increased in the western countries within the past decades. Atopic disorders are among others: food allergy, atopic dermatitis, allergic rhinitis, bronchial asthma, ...
Eligibility Criteria
Inclusion
- patients are at least 6 years old
- patients with a proven moderate to severe atopic disorder who are planned to receive a biologic systemic therapy
- at least one additional proven atopic disorder
Exclusion
- \<2 atopic disorders
- poor compliance
- pregnancy or breastfeeding
Key Trial Info
Start Date :
December 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05334940
Start Date
December 8 2022
End Date
August 31 2025
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany, 10117